Reversal of bretylium blockade of adrenergic nerve terminals by tetraethylammonium. | Biochem Pharmacol;27(10): 1512-3, 1978 May 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Reversal of bretylium blockade of adrenergic nerve terminals by tetraethylammonium.

Kirpekar, M; Kirpekar, S M; Prat, J C.

Biochem Pharmacol ; 27(10): 1512-3, 1978 May 15.

Article in En | MEDLINE | ID: mdl-697893

Subject(s)

Bretylium Compounds/antagonists & inhibitors; Nerve Endings/drug effects; Sympathetic Nervous System/drug effects; Tetraethylammonium Compounds/pharmacology; Animals; Cats; Norepinephrine/metabolism; Spleen/drug effects; Spleen/metabolism; Time Factors

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Sympathetic Nervous System / Bretylium Compounds / Tetraethylammonium Compounds / Nerve Endings Limits: Animals Language: En Journal: Biochem Pharmacol Year: 1978 Document type: Article Country of publication: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Sympathetic Nervous System / Bretylium Compounds / Tetraethylammonium Compounds / Nerve Endings Limits: Animals Language: En Journal: Biochem Pharmacol Year: 1978 Document type: Article Country of publication: United kingdom